Biotech · Private company · San Francisco, CA, US

Xcellassay, Inc.

Track this companyFree. Adds Xcellassay, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

Multiplexed Nuclear Receptor BioAssay platform to inexpensively and broadly survey the nation's water supply for contamination by endocrine disrupting chemicalsFiscal year 2026 · $1.1MNIH RePORTER 2R44ES036049-02 · fetched Nov 12, 2026
Meeting the cost and privacy demands for detecting Anabolic Androgenic Steroid doping in youth athletics with rationally designed nuclear receptor BioAssaysFiscal year 2025 · $306.9KNIH RePORTER 1R43DA059306-01A1 · fetched Nov 12, 2026
Multiplexed Nuclear Receptor BioAssay platform to inexpensively and broadly survey the nation's water supply for contamination by endocrine disrupting chemicalsFiscal year 2024 · $295.9KNIH RePORTER 1R43ES036049-01 · fetched Nov 12, 2026
One-step, in-the-field detection of water contamination by unhealthy concentrations of Endocrine Disrupting Chemicals affecting Nuclear Receptors arrayed on a test stripFiscal year 2024 · $306.9KNIH RePORTER 1R43ES036903-01 · fetched Nov 12, 2026